Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Intimate Rose

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Intimate Rose head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 258 · Grade C

Intimate Rose

Visit Intimate Rose Full brief →

FDA warning letter, September 2025 — issued to Intimate Rose. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Intimate Rose a bad call — it's best for readers comparing oral compounded options who can obtain a drug-specific quote and understand the subscription before submitting intake. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
68
Transparency
90
72
Access Breadth
93
62
Clinical Oversight
92
76
Track Record
88
43
CoreAge RxBrief Score 94 · 65Intimate Rose

Price, coverage & the tracker

CoreAge RxIntimate Rose
Brief Score94/100 (A)65/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm drug-specific quote

Shared weight-loss offer from $169/month; oral compounded semaglutide is listed.

Consent describes monthly renewal and first charge at intake; cancel at least 72 hours before billing.

Full price details

Named semaglutide quote unknown; oral compounded program advertised alongside a shared from $169/month weight-loss price

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm drug-specific quote

Shared weight-loss offer from $169/month; oral compounded tirzepatide is listed.

Consent describes monthly renewal and first charge at intake; cancel at least 72 hours before billing.

Full price details

Named tirzepatide quote unknown; oral compounded program advertised alongside a shared from $169/month weight-loss price

CoverageUS only; restrictions by state, confirmed at intakeWeight-care eligibility depends on the treating provider and patient location; complete current state list unconfirmed.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Intimate Rose: Confirm the drug-specific charge before intake: consent says the first month is charged when intake is completed, with a 72-hour renewal cancellation deadline.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.